Literature DB >> 12646178

Regulation of YB-1 gene expression by GATA transcription factors.

Hisayuki Yokoyama1, Hideo Harigae, Shinichiro Takahashi, Satoru Takahashi, Kazumichi Furuyama, Mitsuo Kaku, Masayuki Yamamoto, Takeshi Sasaki.   

Abstract

GATA-1 is a transcription factor essential for erythroid cell development, and knockdown of GATA-1 gene results in maturation arrest and transformation of erythroblasts. To clarify the mechanism that gives rise to this abnormal phenotype, genes that are aberrantly expressed in the spleen of heterozygous GATA-1 knockdown mutant mouse (referred to as GATA-1 mutant mouse) were identified by using cDNA array. One of these genes, YB-1, was found to be highly expressed in the spleen of GATA-1 mutant mouse. Reporter and electrophoretic mobility shift assays revealed that the proximal GATA element in 5'-UTR region of YB-1 gene functions positively in K562 cells. Furthermore, both GATA-1 and GATA-2, which were transiently expressed in COS-7 cells, bound to this element and activated the YB-1 promoter through this element. These results suggest that YB-1 functions under the regulation of GATA factors in erythroid differentiation and aberrant expression of YB-1 gene may result in dyserythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646178     DOI: 10.1016/s0006-291x(03)00296-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein.

Authors:  Sebastiaan van Zalen; Alyssa A Lombardi; Grace R Jeschke; Elizabeth O Hexner; J Eric Russell
Journal:  Mech Dev       Date:  2015-02-23       Impact factor: 1.882

2.  YB-1 transcription in the postnatal brain is regulated by a bHLH transcription factor Math2 through an E-box sequence in the 5'-UTR of the gene.

Authors:  Sachiyo Ohashi; Reiko Fukumura; Takashi Higuchi; Shunsuke Kobayashi
Journal:  Mol Cell Biochem       Date:  2009-02-19       Impact factor: 3.396

3.  YBX1 expression and function in early hematopoiesis and leukemic cells.

Authors:  Jasjeet Bhullar; Vincent E Sollars
Journal:  Immunogenetics       Date:  2011-03-03       Impact factor: 2.846

4.  Interplay between Y-box-binding protein 1 (YB-1) and poly(A) binding protein (PABP) in specific regulation of YB-1 mRNA translation.

Authors:  Dmitry N Lyabin; Irina A Eliseeva; Olga V Skabkina; Lev P Ovchinnikov
Journal:  RNA Biol       Date:  2011-07-26       Impact factor: 4.652

5.  High expression of YB-1 gene in erythroid cells in patients with refractory anemia.

Authors:  Hisayuki Yokoyama; Hideo Harigae; Shinichiro Takahashi; Junichi Kameoka; Koichi Miyamura; Kenichi Ishizawa; Mitsuo Kaku; Takeshi Sasaki
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

6.  Comparative Transcriptomic Analysis of the Hematopoietic System between Human and Mouse by Single Cell RNA Sequencing.

Authors:  Shouguo Gao; Zhijie Wu; Jeerthi Kannan; Liza Mathews; Xingmin Feng; Sachiko Kajigaya; Neal S Young
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

Review 7.  Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Authors:  Thomas G Johnson; Karin Schelch; Sunali Mehta; Andrew Burgess; Glen Reid
Journal:  Front Cell Dev Biol       Date:  2019-10-01

8.  Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Authors:  Golareh Habibi; Samuel Leung; Jennifer H Law; Karen Gelmon; Hamid Masoudi; Dmitry Turbin; Michael Pollak; Torsten O Nielsen; David Huntsman; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2008-10-16       Impact factor: 6.466

9.  YB-1 synthesis is regulated by mTOR signaling pathway.

Authors:  Dmitry N Lyabin; Irina A Eliseeva; Lev P Ovchinnikov
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.